For quite some time now, investors have fought the suggestion that the artificial intelligence industry may be forming a massive bubble, risking an eventual collapse of epic proportions that could ...

This weekend's college basketball slate is highlighted by big-time games between huge brands. Look no further than Saturday's highly anticipated top-15 showdown between No. 4 Duke and No. 14 North ...

When bubbles burst, what comes next can be better, if we build it differently It was December 1999. Tech investors were riding high, convinced that a website and a Super Bowl ad were all it took to ...

AI’s success or failure will depend on whether it can start to show the worth of massive investments. And today, the Trump administration’s tariffs and immigration policies are a big part of what’s ...

Shannon O'Neil is senior vice president and director of studies at the Council on Foreign Relations and author of "The Globalization Myth: Why Regions Matter." AI is driving the S&P 500 index and the ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Artificial intelligence stocks have led the S&P 500 higher as the bull market marches on. But some investors today worry about how long the momentum will last. Certain AI stocks have seen their ...

It's one of the most exciting things to watch yet one of the most excruciating places to be in college basketball: the NCAA tournament bubble. Even though Selection Sunday is more than 50 days away, ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Here's a question with trillion-dollar consequences for the economy. Are we in an AI bubble or not? Planet Money's Jeff Guo runs us through some of the signs economists are looking for to get an ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...